Skip to main content

Clinical Collaboration Platform CVE-2020-16247

HIGH
Configuration (CWE-16)
2020-09-18 ics-cert@hq.dhs.gov
7.1
CVSS 3.1 · NVD
Share

Severity by source

NVD PRIMARY
7.1 HIGH
AV:L/AC:L/PR:L/UI:N/S:U/C:H/I:H/A:N

Primary rating from NVD · only source for this CVE.

CVSS VectorNVD

CVSS:3.1/AV:L/AC:L/PR:L/UI:N/S:U/C:H/I:H/A:N
Attack Vector
Local
Attack Complexity
Low
Privileges Required
Low
User Interaction
None
Scope
Unchanged
Confidentiality
High
Integrity
High
Availability
None

Lifecycle Timeline

1
CVE Published
Sep 18, 2020 - 18:15 nvd
HIGH 7.1

DescriptionNVD

Philips Clinical Collaboration Platform, Versions 12.2.1 and prior,

exposes a resource to the wrong control sphere, providing unintended actors with inappropriate access to the resource.

AnalysisAI

Philips Clinical Collaboration Platform, Versions 12.2.1 and prior, exposes a resource to the wrong control sphere, providing unintended actors with inappropriate access to the resource. Rated high severity (CVSS 7.1), this vulnerability is low attack complexity. No vendor patch available.

Technical ContextAI

This vulnerability is classified under CWE-16. Philips Clinical Collaboration Platform, Versions 12.2.1 and prior, exposes a resource to the wrong control sphere, providing unintended actors with inappropriate access to the resource. Affected products include: Philips Clinical Collaboration Platform.

RemediationAI

No vendor patch is available at time of analysis. Monitor vendor advisories for updates. Apply vendor patches when available. Implement network segmentation and monitoring as interim mitigations.

Share

CVE-2020-16247 vulnerability details – vuln.today

This site uses cookies essential for authentication and security. No tracking or analytics cookies are used. Privacy Policy